CET Announcing Products for iPS Cell Lines.

 

January 2013

 

CET now offers several iPS cell lines for research applications. Using our proprietary technology these cell lines have been created using our novel viral-based gene constructs that contains modified Yamanaka factors with different protein structures. iPS cells were created by reprogramming the following target cells: Human Foreskin Fibroblast, Cord blood multipotent stem cell and Alzheimer Disease with Presenillin-1 mutation. For further details, please see our product page for these cell lines.